2,692
Views
11
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR: MEDICAL ONCOLOGY

The impact of smoking on the effectiveness of immune checkpoint inhibitors — a systematic review and meta-analysis

, , , , , , , & show all
Pages 96-100 | Received 11 Aug 2019, Accepted 16 Sep 2019, Published online: 25 Sep 2019

Figures & data

Figure 1. Flow diagram showing inclusion and exclusion of studies.

Figure 1. Flow diagram showing inclusion and exclusion of studies.

Figure 2. Forest plot of hazard ratios for overall survival comparing immune checkpoint inhibitors versus chemotherapy in ever-smokers and never-smokers patient subgroups. Hazard ratio for each trial is represented by the square and the horizontal line crossing the square represents the 95% confidence interval (CI). The diamond represents the pooled overall effect size estimated using a fixed-effect meta-analysis. All statistical tests were two-sided. *Hazard ratio could not be estimated for never-smoker subgroup because there were only 17 patients in CHECKMATE 017 trial.

Figure 2. Forest plot of hazard ratios for overall survival comparing immune checkpoint inhibitors versus chemotherapy in ever-smokers and never-smokers patient subgroups. Hazard ratio for each trial is represented by the square and the horizontal line crossing the square represents the 95% confidence interval (CI). The diamond represents the pooled overall effect size estimated using a fixed-effect meta-analysis. All statistical tests were two-sided. *Hazard ratio could not be estimated for never-smoker subgroup because there were only 17 patients in CHECKMATE 017 trial.
Supplemental material

Supplemental Material

Download PDF (1.7 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.